Nutrition

Pop Quiz: Omega-3 Fatty Acids and CV Health

“A Clinician’s Guide for Trending Cardiovascular Nutrition Controversies: Part II” outlines 10 controversies about cardiovascular nutrition. Browse the guide, then take our Pop Quiz to see what you’ve learned!

Current Consultant Issue

Previous Issues

Early View

Research Summaries

Research Summary

Semaglutide Reduces Abdominal VAT in Patients With HIV-Related Lipohypertrophy

12/11/2024

Miranda Manier, BA

A clinical trial suggests semaglutide significantly reduces abdominal fat in HIV-associated lipohypertrophy, but the potential for adverse events warrant further investigation.

12/11/2024

Conference Coverage

Mosunetuzumab as a Treatment Option for Patients With Relapsed or Refractory Mantle Cell Lymphoma

12/10/2024

Anthony Calabro, MA

Researchers report on the first safety and efficacy of mosunetuzumab, a CD20xCD3 T-cell engaging bispecific antibody, for patients with relapsed/refractory Mantle cell lymphoma. This study was presented at...

12/10/2024

Conference Coverage

Conference Coverage

How Effective Is the Ibrutinib-Venetoclax-Obinutuzumab Triplet in Mantle Cell Lymphoma?

12/10/2024

Miranda Manier, BA

The OASIS trial evaluates the efficacy of ibrutinib, venetoclax, and obinutuzumab in newly diagnosed mantle cell lymphoma, reporting a 5-year progression-free survival (PFS) rate of 80% and overall survival...

12/10/2024

Conference Coverage

Patients with Mantle Cell Lymphoma Treated With cBTKi With and Without Cytotoxic Chemotherapy

12/09/2024

Anthony Calabro, MA

Researchers analyzed data from a nationwide cohort to evaluate the effectiveness of covalent Bruton tyrosine kinase inhibitors, used either as monotherapy or in combination with anti-CD20 monoclonal...

12/09/2024

Research Summary

Illustration of an x-ray of person's body, with the kidneys highlighted.

Research Summary

Study: Obinutuzumab Improves Kidney Outcomes in Lupus Nephritis

12/09/2024

Miranda Manier, BA

Post hoc analyses of the phase 2 NOBILITY trial reveal that adding obinutuzumab to standard lupus nephritis therapy enhances kidney preservation and reduces glucocorticoid reliance.

12/09/2024

Trending Articles

Pop Quiz

What Do You Know About Endometrial Cancer?

11/11/2024

The risk for endometrial cancer increases as women get older. Which of the following is NOT a risk factor for endometrial cancer?A. Overweight and obesityB. Family historyC. Having multiple childrenD....

11/11/2024

Roundtable

Roundtable

Initiating Resmetirom for Patients With MASH: Recommendations on Patient Selection, Treatment Response, and Patient Monitoring

12/12/2024

In this video, Naim Alkhouri MD, FAASLD, moderates a roundtable discussion with Amreen M. Dinani, MD, FRCPC, and Mazen Noureddin, MD, MHSc, on the practical clinical applications associated with...

12/12/2024

ROUNDTABLE

ROUNDTABLE

Key Updates on the Treatment and Management of MASH

10/08/2024

In this video, James Matera, DO, moderates a roundtable discussion with Colin Browm, MD, Kunal Gupta MD, and Lisa Jones, MA, RDN, LDN, FAND, on recent developments regarding the treatment and management...

10/08/2024

Sponsored

What Do You Know About Continuous Glucose Monitoring?

12/05/2024

True or false: Even with coverage, most patients will have to pay $80+ for a CGM.A. TrueB. FalseTrue or false: It is common for patients with diabetes to struggle with fingersticks when self-monitoring...

12/05/2024

Photoclinic Challenge

Can You Make a Diagnosis Based on This Image?

08/19/2015

What is your diagnosis based on the case description, patient history, image, and key hint?A. Kawasaki diseaseB. Mycoplasma pneumoniae-induced rash and mucositis (MIRM)C. Stevens-Johnson syndromeD. Toxic...

08/19/2015

lupus

A Collection of Lupus Manifestations

05/21/2015

Pericardial Effusion with Heart Failure: Initial Sign of SLE in Teenage Girl Chyi-sen WU, MD, Chia-Wai Chang, MD, and Kong-Sang Wan, MD, PhD A 13-year-old girl was admitted...

Consultant. 2015;55(5):378-383

05/21/2015